British American Tobacco PLC
Manufactures and sells tobacco and nicotine products globally, including cigarettes, vapour devices, heated products, and modern oral alternatives, under brands such as Dunhill, Kent, Lucky Strike, Pall Mall, and Vuse.
As of Aug 28, 2026
Summary
British American Tobacco is a global tobacco and nicotine products company trading on the London Stock Exchange at 4,129p per share. The technical setup reads bullish despite a one-month pullback of minus 9.6 percent, whilst the stock has gained 5.2 percent over the past year. With a market capitalisation of £88.9 billion, the company currently carries a neutral near-term bias with today's price down 0.6 percent.
Price history
As of Aug 28, 2026
Performance
+0.00%
-0.05%
-9.57%
-7.55%
+0.72%
+5.23%
As of Aug 28, 2026
Technical indicators
- 40.5
- 4.26Bullish
- 50: 4442.9 · 200: 4329.08
- 4,090p / 4,273p
Technical Bias
Bullish lean
The technical picture for British American Tobacco shows a mixed backdrop with a slight bullish lean. MACD momentum is positive, but RSI sits in neutral territory and the price is trading between moving averages without a clear directional confirmation. This is a derived technical read, not a recommendation.
A transparent read of the indicators below — not a prediction or recommendation.
As of Aug 28, 2026
Fundamentals
- £88.9B
- 14.19
- 2.91p
- 24.99%
- +1.4%
- £4.36B
- 0.13
- 3,526p – 5,004p
- 5.90%
- Oct 1, 2026
- —
As of Aug 31, 2026
Upcoming catalysts
- Ex-dividend date
As of Aug 31, 2026
Latest news
As of Aug 31, 2026
MonkeyTrade's Take on British American Tobacco PLC
Short-term outlook
The technical picture on British American Tobacco leans cautiously bullish, though not decisively so. MACD is holding a bullish signal even as RSI sits neutral at 40.5, and the shares trade between their 50-day (4,442.9p) and 200-day (4,329.08p) averages after a rough month, down 9.6%. A break above 4,273p resistance would strengthen the case for a near-term recovery, while a slide through 4,090p support would undercut it, and with no earnings date in view, price action alone should set the tone.
Medium-term outlook
British American Tobacco's numbers point to a steady, cash-generative business: a modest 1.4% revenue growth, a solid 25% profit margin, and a chunky 5.9% dividend yield, all trading on a modest 14.19 P/E. With the technical lean also bullish, the medium-term picture favours continued strength. A slowdown in revenue growth or margin compression would be the key trigger to revisit that stance.
Key risks
- Revenue growth of just +1.4% year-on-year suggests the core tobacco business is finding it hard to generate much fresh momentum.
- The announced cut of 5,500 jobs points to a restructuring effort that carries execution risk and could signal cost pressures within the business.
- After a reported 43% gain over the year, with commentary flagging a DCF valuation gap, the shares may already be pricing in a
About British American Tobacco PLC
British American Tobacco PLC is a UK-listed consumer defensive company operating in the tobacco industry, trading on the London Stock Exchange under the ticker BATS. With a market capitalisation of £88.9B, it stands as one of the larger names in its sector, reflecting a significant global footprint in a business built on established, non-cyclical consumer demand.
The company's key figures give a sense of how the market currently views it. A price-to-earnings ratio of 14.19 points to a valuation that sits in line with a mature, cash-generative business rather than a high-growth one. Meanwhile, a dividend yield of +5.9% highlights BATS's role as an income-focused holding, a common characteristic among tobacco companies that prioritise returning cash to shareholders over reinvesting for expansion.
How to trade British American Tobacco PLC
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.